Locally administered zoledronic acid therapy for giant cell tumor of bone

Orthopedics

Volumn 34, Issue 7, 2011, Pages

  Nishisho, Toshihiko ^a   Hanaoka, Naoyoshi ^a   Endo, Kenji ^a   Takahashi, Mitsuhiko ^a   Yasui, Natsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; ZOLEDRONIC ACID;

ADULT; ARTICLE; BONE BIOPSY; BONE GRAFT; BONE TRANSPLANTATION; CASE REPORT; CELL DEATH; CURETTAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KNEE; KNEE FUNCTION; KNEE PAIN; KNEE RADIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCLAST; OSTEOCLASTOMA; PEROPERATIVE CARE; RANGE OF MOTION; STROMA CELL; TUMOR CELL;

ADULT; ANTINEOPLASTIC AGENTS; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; BONE SUBSTITUTES; BONE TRANSPLANTATION; CURETTAGE; DIPHOSPHONATES; GIANT CELL TUMOR OF BONE; HUMANS; HYDROXYAPATITES; IMIDAZOLES; KNEE JOINT; MALE; NECROSIS; OSTEOCLASTS; OSTEOLYSIS; PROSTHESES AND IMPLANTS; RANGE OF MOTION, ARTICULAR; REMISSION INDUCTION; TIBIA;

EID: 79960193241     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20110526-22     Document Type: Article

References (20)

1. Thomas DM, Skubitz KM. Giant cell tumour of bone. Curr Opin Oncol. 2009; 21(4):338-344.
2. Arbeitsgemeinschaft Knochentumoren, Becker WT, Dohle J, et al. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am. 2008; 90(5):1060-1067. (Pubitemid 351632651)
3. Amanat N, Brown R, Bilston LE, Little DG. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair [published online ahead of print April 19, 2005]. J Orthop Res. 2005; 23(5):1029-1034. (Pubitemid 41245425)
4. Omi H, Kusumi T, Kijima H, Toh S. Locally administered low-dose alendronate increases bone mineral density during distraction osteogenesis in a rabbit model. J Bone Joint Surg Br. 2007; 89(7):984-988. (Pubitemid 47322804)
5. Ladanyi M, Traganos F, Huvos AG. Benign metastasizing giant cell tumors of bone. A DNA flow cytometric study. Cancer. 1989; 64(7):1521-1526. (Pubitemid 19238972)
6. Turcotte RE, Wunder JS, Isler MH, et al. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002; (397):248-258. (Pubitemid 34442036)
7. Errani C, Ruggieri P, Asenzio MA, et al. Giant cell tumor of the extremity: A review of 349 cases from a single institution [published online ahead of print October 30, 2009]. Cancer Treat Rev. 2010; 36(1):1-7.
8. Hughes DE, Wright KR, Uy HL, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res. 1995; 10(10):1478-1487.
9. Arpornchayanon O, Leerapun T. Effectiveness of intravenous bisphosphonate in treatment of giant cell tumor: a case report and review of the literature. J Med Assoc Thai. 2008; 91(10):1609-1612.
10. Cheng YY, Huang L, Lee KM, Xu JK, Zheng MH, Kumta SM. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Calcif Tissue Int. 2004; 75(1):71-77. (Pubitemid 38989221)
11. Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study [published online ahead of print September 6, 2007]. Bone. 2008; 42(1):68-73. (Pubitemid 350297173)
12. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004; 62(5):527-534. (Pubitemid 38542516)
13. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003; 61(9):1115-1117. (Pubitemid 37064711)
14. Ezra A, Golomb G. Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv Drug Deliv Rev. 2000; 42(3):175-195. (Pubitemid 30645777)
15. Goldring SR, Roelke MS, Petrison KK, Bhan AK. Human giant cell tumors of bone identification and characterization of cell types. J Clin Invest. 1987; 79(2):483-491. (Pubitemid 17009684)
16. Wulling M, Engels C, Jesse N, Werner M, Delling G, Kaiser E. The nature of giant cell tumor of bone. J Cancer Res Clin Oncol. 2001; 127(8):467-474. (Pubitemid 32662503)
17. Fromigue O, Lagneaux L, Body JJ. Bisphosphonates induce breast cancer cell death in vitro. J Bone Miner Res. 2000; 15(11):2211-2221.
18. Tassone P, Tagliaferri P, Viscomi C, et al. Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br J Cancer. 2003; 88(12):1971-1978. (Pubitemid 36829676)
19. Zwolak P, Manivel JC, Jasinski P, et al. Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines. J Bone Joint Surg Am. 2010; 92(1):162-168.
20. Weiss HM, Pfaar U, Schweitzer A, Wiegand H, Skerjanec A, Schran H. Biodistribution and plasma protein binding of zoledronic acid [published online ahead of print July 14, 2008]. Drug Metab Dispos. 2008; 36(10):2043-2049.